Shrunken confidence in government health programs is one reason the drug isn’t reaching those who need it.
In this photo illustration, Pfizer’s Paxlovid is displayed on July 07, 2022 in Pembroke Pines, Florida. Evangelical minister Eddie Hyatt believes in the healing power of prayer but “also the medical approach.” So on a February evening a week before scheduled prostate surgery, he had his sore throat checked out at an emergency room near his home in Grapevine, Texas.
The price is one reason Paxlovid is not reaching those who need it most. And patients who qualify for free doses, which Pfizer offers“If you want to create a barrier to people getting a treatment, making it cost a lot is the way to do it,” said William Schaffner, a professor at Vanderbilt University School of Medicine and spokesperson for the National Foundation for Infectious Diseases.
That’s what rescued Hyatt, whose Department of Veterans Affairs health plan doesn’t normally cover outpatient drugs. While he searched on his phone for a solution, the pharmacist’s assistant suddenly appeared from the store. “It won’t cost you anything!” she said.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Antiviral Drug Paxlovid May Not Benefit Low-Risk COVID-19 PatientsThe antiviral drug Paxlovid may not be particularly helpful for patients who are not at high risk for severe COVID-19. However, although the rate of hospitalization and death from any cause was low overall, the group that received Paxlovid had a reduced rate compared with people in the placebo group, according to the researchers. The time from onset to relief of COVID-19 symptoms did not differ significantly between the two study groups. The median time to sustained alleviation of symptoms was 12 days for the Paxlovid group compared with 13 days in the placebo group.
Read more »
Scientist Reveals How To Regrow Your Age-Shrunken Brain in Just Six MonthsResearch shows that losing cognitive function in old age may not be inevitable and simple measures can help extend the brain's health span.
Read more »
Why is Japan changing its ban on exporting lethal weapons, and why is it so controversial?Japan’s Cabinet OK’d a plan to sell future next-generation fighter jets to other countries on Tuesday, its latest step away from the pacifist principles the country adopted at the end of World War II.
Read more »
Why is Japan changing its ban on exporting lethal weapons, and why is it so controversial?Japan’s Cabinet OK’d a plan to sell future next-generation fighter jets to other countries on Tuesday, its latest step away from the pacifist principles the country adopted at the end of World War II.
Read more »
Why is Japan changing its ban on exporting lethal weapons, and why is it so controversial?Japan’s Cabinet OK’d a plan to sell future next-generation fighter jets to other countries on Tuesday, its latest step away from the pacifist principles the country adopted at the end of World War II.
Read more »
Why is Japan changing its ban on exporting lethal weapons, and why is it so controversial?Japan’s Cabinet OK’d a plan to sell future next-generation fighter jets to other countries on Tuesday, its latest step away from the pacifist principles the country adopted at the end of World War II
Read more »